Skip to main content

Neuroprotective Effects of Ethyl Pyruvate on Brain Energy Metabolism after Ischemia-Reperfusion Injury: A 31P-Nuclear Magnetic Resonance Study

Abstract

The neuroprotective effects of ethyl pyruvate (EP), a stable derivative of pyruvate, on energy metabolism of rat brain exposed to ischemia-reperfusion stress were investigated by 31P-nuclear magnetic resonance (31P-NMR) spectroscopy. Recovery level of phosphocreatine after ischemia was significantly greater when superfused with artificial cerebrospinal fluid (ACSF) with 2 mM EP than when superfused with ACSF without EP. EP was neuroprotective against ischemia only when administered before the ischemic exposure. Intracellular pH during ischemia was less acidic when superfused ahead of time with EP. EP did not show neuroprotective effects in neuron-rich slices pretreated with 100 μM fluorocitrate, a selective glial poison. It was suggested that both the administration of EP before ischemic exposure and the presence of astrocytes are required for EP to exert neuroprotective effects. We suggest the potential involvement of multiple mechanisms of action, such as less acidic intracellular pH, glial production of lactate, and radical scavenging ability.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

References

  1. Fink MP (2003) Ethyl pyruvate: a novel anti-inflammatory agent. Crit Care Med 31(Suppl):S51–S56. doi:10.1097/00003246-200301001-00008

    PubMed  Article  CAS  Google Scholar 

  2. González-Falcón A, Candelario-Jalil E, García-Cabrera M, León OS (2003) Effects of pyruvate administration on infarct volume and neurological deficits following permanent focal cerebral ischemia in rats. Brain Res 990:1–7. doi:10.1016/S0006-8993(03)03378-X

    PubMed  Article  CAS  Google Scholar 

  3. Varma SD, Hegde KR (2007) Lens thiol depletion by peroxynitrite. Protective effect of pyruvate. Mol Cell Biochem 298:199–204. doi:10.1007/s11010-006-9352-y

    PubMed  Article  CAS  Google Scholar 

  4. Cicalese L, Lee K, Schraut W et al (1996) Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine. Am J Surg 171:97–101. doi:10.1016/S0002-9610(99)80081-6

    PubMed  Article  CAS  Google Scholar 

  5. Mongan PD, Capacchione J, Fontana JL et al (2001) Pyruvate improves cerebral metabolism during hemorrhagic shock. Am J Physiol Heart Circ Physiol 281:H854–H864

    PubMed  CAS  Google Scholar 

  6. Lee JY, Kim YH, Koh JY (2001) Protection by pyruvate against transient forebrain ischemia in rats. J Neurosci 21:RC171

    PubMed  CAS  Google Scholar 

  7. Zeng J, Yang GY, Ying W et al (2007) Pyruvate improves recovery after PARP-1-associated energy failure induced by oxidative stress in neonatal rat cerebrocortical slices. J Cereb Blood Flow Metab 27:304–315. doi:10.1038/sj.jcbfm.9600335

    PubMed  Article  CAS  Google Scholar 

  8. Bunton CA (1949) Oxidation of α-diketones and α-keto-acids by hydrogen peroxide. Nature 163:444. doi:10.1038/163444a0

    Article  CAS  Google Scholar 

  9. O’Donnell-Tormey J, Nathan CF, Lanks K et al (1987) Secretion of pyruvate an antioxidant defense of mammalian cells. J Exp Med 165:500–514. doi:10.1084/jem.165.2.500

    PubMed  Article  CAS  Google Scholar 

  10. Brand KA, Hermfisse U (1997) Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 11:388–395

    PubMed  CAS  Google Scholar 

  11. Montgomery CM, Webb JL (1956) Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. J Biol Chem 221:359–368

    PubMed  CAS  Google Scholar 

  12. Sims CA, Wattanasirichaigoon S, Menconi MJ et al (2001) Ringer’s ethyl pyruvate solution ameliorates ischemia/reperfusion induced intestinal mucosal injury in rats. Crit Care Med 29:1513–1518. doi:10.1097/00003246-200108000-00003

    PubMed  Article  CAS  Google Scholar 

  13. Fink MP (2007) Ethyl pyruvate: a novel anti-inflammatory agent. J Intern Med 261:349–362. doi:10.1111/j.1365-2796.2007.01789.x

    PubMed  Article  CAS  Google Scholar 

  14. Kim JB, Yu YM, Kim SW et al (2005) Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 1060:188–192. doi:10.1016/j.brainres.2005.08.029

    PubMed  Article  CAS  Google Scholar 

  15. Lin RY, Vera JC, Chaganti RSK et al (1998) Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter. J Biol Chem 44:28959–28965. doi:10.1074/jbc.273.44.28959

    Article  Google Scholar 

  16. Zeng J, Liu J, Yang GY et al (2007) Exogenous ethyl pyruvate versus pyruvate during metabolic recovery after oxidative stress in neonatal rat cerebrocortical slices. Anesthesiology 107:630–640

    PubMed  Article  CAS  Google Scholar 

  17. Woo YJ, Taylor MD, Cohen JE et al (2004) Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg 127:1262–1269. doi:10.1016/j.jtcvs.2003.11.032

    PubMed  Article  CAS  Google Scholar 

  18. Ulloa L, Ochani M, Yang H et al (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99:12351–12356. doi:10.1073/pnas.192222999

    PubMed  Article  CAS  Google Scholar 

  19. Yang R, Gallo DJ, Baust JJ et al (2002) Ethyl pyruvate modulates inflammatory gene expression in mice subject to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 283:G212–G221

    PubMed  CAS  Google Scholar 

  20. Sappington PL, Fink ME, Yang R et al (2003) Ethyl pyruvate provides durable protection against inflammation-induced intestinal epithelial barrier dysfunction. Shock 20:521–528. doi:10.1097/01.shk.0000092697.10326.8b

    PubMed  Article  CAS  Google Scholar 

  21. Han Y, Englert JA, Yang R et al (2005) Ethyl pyruvate inhibits nuclear factor-κB-dependent signaling by directly targeting p65. J Pharmacol Exp Ther 312:1097–1105. doi:10.1124/jpet.104.079707

    PubMed  Article  CAS  Google Scholar 

  22. Takei M, Kawano Y, Yamada K (1992) Phosphorus nuclear magnetic resonance studies on the calcium-dependent energy metabolism of rat cerebrum under conditions of potassium in vitro. Neurosci Res 12:596–605. doi:10.1016/0168-0102(92)90066-L

    PubMed  Article  CAS  Google Scholar 

  23. Yoshioka K, Nisimaru N, Yanai S et al (2000) Characteristics of monocarboxylates as energy substrates other than glucose in rat brain slices and the effect of selective glial poisoning-a 31P-NMR study. Neurosci Res 36:215–226. doi:10.1016/S0168-0102(99)00124-8

    PubMed  Article  CAS  Google Scholar 

  24. Kitano T, Nisimaru N, Shibata E et al (2002) Lactate utilization as an energy substrate in ischemic preconditioned rat brain slices. Life Sci 72:557–564. doi:10.1016/S0024-3205(02)02251-8

    PubMed  Article  CAS  Google Scholar 

  25. Kitano T, Nisimaru N, Shibata E et al (2003) Monocarboxylates and glucose utilization as energy substrates in rat brain slices under selective glial poisoning-a 31P NMR study. Mol Cell Biochem 244:77–81. doi:10.1023/A:1022461118479

    PubMed  Article  CAS  Google Scholar 

  26. Tokumaru O, Kitano T, Takei H et al (2006) Effects of gamma ray irradiation on energy metabolism in the rat brain: a 31P nuclear magnetic resonance spectroscopy study. J Neurosurg 105(Suppl):202–207. doi:10.3171/sup.2006.105.7.202

    PubMed  Google Scholar 

  27. Petroff OAC, Prichard JW, Behar KL et al (1985) Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy. Neurology 35:781–788

    PubMed  CAS  Google Scholar 

  28. Clarke DD, Nicklas WJ, Berl S (1970) Tricarboxylic acid-cycle metabolism in brain. Effect of fluoroacetate and fluorocitrate on the labelling of glutamate, aspartate, glutamine and γ-aminobutyrate. Biochem J 120:345–351

    PubMed  CAS  Google Scholar 

  29. Paulsen RE, Contestabile A, Villani L et al (1987) An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate. J Neurochem 48:1377–1385. doi:10.1111/j.1471-4159.1987.tb05674.x

    PubMed  Article  CAS  Google Scholar 

  30. Yokoi I, Toma J, Liu J et al (1995) Adenosines scavenged hydroxyl radicals and prevented posttraumatic epilepsy. Free Radic Biol Med 19:473–479. doi:10.1016/0891-5849(95)00050-8

    PubMed  Article  CAS  Google Scholar 

  31. R Development Core Team (2008) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org

  32. Flamm ES, Demopoulos HB, Seligman ML et al (1978) Free radicals in cerebral ischemia. Stroke 9:445–447

    PubMed  CAS  Google Scholar 

  33. Peters O, Back T, Lindauer U et al (1998) Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 18:196–205. doi:10.1097/00004647-199802000-00011

    PubMed  Article  CAS  Google Scholar 

  34. Yu YM, Kim JB, Lee KW et al (2005) Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke 36:2238–2243. doi:10.1161/01.STR.0000181779.83472.35

    PubMed  Article  CAS  Google Scholar 

  35. Magistretti PJ, Pellerin L, Rothman DL et al (1999) Energy on demand. Science 283:496–497. doi:10.1126/science.283.5401.496

    PubMed  Article  CAS  Google Scholar 

  36. Hyder F, Patel AB, Gjedde A et al (2006) Neuronal–glial glucose oxidation and glutamatergic–GABAergic function. J Cereb Blood Flow Metab 26:865–877. doi:10.1038/sj.jcbfm.9600263

    PubMed  Article  CAS  Google Scholar 

  37. Schurr A, Payne RS, Miller JJ et al (1997) Glia are the main source of lactate utilized by neurons for recovery of function posthypoxia. Brain Res 774:221–224. doi:10.1016/S0006-8993(97)81708-8

    PubMed  Article  CAS  Google Scholar 

  38. Schurr A (2006) Lactate: the ultimate cerebral oxidative energy substrate? J Cereb Blood Flow Metab 26:142–152. doi:10.1038/sj.jcbfm.9600174

    PubMed  Article  CAS  Google Scholar 

  39. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 91:10625–10629. doi:10.1073/pnas.91.22.10625

    PubMed  Article  CAS  Google Scholar 

  40. Desagher S, Glowinski J, Premont J (1996) Astrocytes protect neurons from hydrogen peroxide toxicity. J Neurosci 16:2553–2562

    PubMed  CAS  Google Scholar 

  41. Zhao G, Flavin MP (2000) Differential sensitivity of rat hippocampal and cortical astrocytes to oxygen-glucose deprivation injury. Neurosci Lett 285:177–180. doi:10.1016/S0304-3940(00)01056-9

    PubMed  Article  CAS  Google Scholar 

  42. Liu D, Smith CL, Barone FC et al (1999) Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Brain Res Mol Brain Res 68:29–41. doi:10.1016/S0169-328X(99)00063-7

    PubMed  Article  CAS  Google Scholar 

  43. Hamby AM, Suh SW, Kauppinen TM et al (2007) Use of a poly(ADPRibose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke 38:632–636. doi:10.1161/01.STR.0000250742.61241.79

    PubMed  Article  CAS  Google Scholar 

  44. Lohmann K (1934) Über die enzymatische Aufspaltung der Kreatinphosphorsäure; zugleich ein Beitrag zum Chemismus der Muskelkontraktion. Biochem Z 271:264–277

    CAS  Google Scholar 

  45. Yager JY, Asselin J (1996) Effect of mild hypothermia on cerebral energy metabolism during the evolution of hypoxic-ischemic brain damage in the immature rat. Stroke 27:919–926

    PubMed  CAS  Google Scholar 

  46. Litt L, Hirai K, Basus VJ et al (2003) Temperature control of respiring rat brain slices during high field NMR spectroscopy. Brain Res Protoc 10:191–198. doi:10.1016/S1385-299X(02)00218-0

    Article  Google Scholar 

  47. Kintner DB, Anderson MK, Fitzpatrick JH Jr et al (2000) 31P-MRS-based determination of brain intracellular and interstitial pH: its application to in vivo H+ compartmentation and cellular regulation during hypoxic/ischemic conditions. Neurochem Res 25:1385–1396. doi:10.1023/A:1007664700661

    PubMed  Article  CAS  Google Scholar 

  48. Zhou FQ (2005) Pyruvate in the correction of intracellular acidosis: a metabolic basis as a novel superior buffer. Am J Nephrol 25:55–63. doi:10.1159/000084141

    PubMed  Article  CAS  Google Scholar 

Download references

Acknowledgments

This study was funded by Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology, Japan to T.K. (# 17591639). The authors express sincere thanks to Dr. Kira Bacal, MD, PhD, MPH for her editing the manuscript and giving invaluable comments.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Osamu Tokumaru.

Additional information

Special issue article in honor of Dr. Akitane Mori.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tokumaru, O., Kuroki, C., Yoshimura, N. et al. Neuroprotective Effects of Ethyl Pyruvate on Brain Energy Metabolism after Ischemia-Reperfusion Injury: A 31P-Nuclear Magnetic Resonance Study. Neurochem Res 34, 775 (2009). https://doi.org/10.1007/s11064-008-9871-x

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11064-008-9871-x

Keywords

  • Ethyl pyruvate
  • Phosphocreatine
  • ATP
  • Brain energy metabolism
  • 31P-NMR
  • Ischemia-reperfusion injury